Peter J. Weiler
CIK: 0002066576
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
EDSA
Edesa Biotech, Inc.
Officer
Discretionary Trading P&L
Holdings
About Weiler Peter J.
Weiler Peter J. (SEC CIK 0002066576) files insider reports with the SEC as Chief Financial Officer of Edesa Biotech, Inc. (EDSA).
Signal8 holds 3 ownership filings by Weiler Peter J. (1 Form 3, 2 Form 4), filed between May 2, 2025 and May 29, 2026. Those filings report 2 transactions, from May 29, 2025 to May 27, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Weiler Peter J.'s filings is in MARKHAM.
Recent filings by Weiler Peter J.
Other insiders filing for Edesa Biotech, Inc. (EDSA)
- Nijhawan Pardeep, Chief Executive Officer
- Marshall Patrick, Director
- MacDonald Sean Arthur, Director
- Chypyha Joan, Director
- Brooks Michael J, President
- Sistilli Carlo, Director